HALOZYME REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL AND OPERATING RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 122.80 -2.03 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $124.83 | 52 Week High | $18.39 | |||
| Open | $124.16 | 52 Week Low | $6.96 | |||
| Day High | $124.91 | P/E | N/A | |||
| Day Low | $122.22 | EPS | $-0.58 | |||
| Volume | 228,272 | |||||
